Botulinum Toxins
Sponsors
VA Connecticut Healthcare System, Yale University, Kaohsiung Veterans General Hospital., Fondation Ophtalmologique Adolphe de Rothschild, Henry Ford Health System
Conditions
Botulinum ToxinBotulinum Toxin InjectionCervicalgiaChronic Anal FissureDystonia; OrofacialHypertrophic ScarItchinessLow Back Pain
Phase 1
Phase 2
A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction
TerminatedNCT02044302
Start: 2014-04-30End: 2016-01-31Updated: 2017-04-10
The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation
CompletedNCT03887377
Start: 2019-06-10End: 2024-12-30Updated: 2025-06-15
Unknown Phase
The Use of Botulinum Toxin in the Treatment of Itching From Hypertrophic Scar -- A Randomised Controlled Trial
NCT02168634
Start: 2013-11-30Target: 60Updated: 2015-10-09
Outcome of Botulinum Toxin Treatment for Oromandibular Dystonia
CompletedNCT03363113
Start: 2016-01-01End: 2016-07-12Updated: 2017-12-06
Postero-lateral Internal Sphincterotomy vs Botulinum Toxin Injection in the Treatment of Chronic Anal Fissure
NCT03920449
Start: 2019-05-01End: 2021-01-01Target: 60Updated: 2020-05-29
Botulinum Toxin Injection in the Treatment of Open Abdomen
RecruitingNCT04283916
Start: 2020-02-21End: 2024-08-31Target: 30Updated: 2024-02-01